Abstract 4179: High valency of IGM-2323, a CD20xCD3 IgM bispecific T cell engager, displaces rituximab binding and induces potent B lymphoma cell killing
Kevin C. Hart(Stanford University), Maya F. Kotturi(Alameda Hospital), Paul R. Hinton(IGM Biosciences (United States)), Mandy Li(IGM Biosciences (United States)), Kathryn Logronio(IGM Biosciences (United States)), Stephen F. Carroll(IGM Biosciences (United States)), Marigold Manlusoc(IGM Biosciences (United States)), Maya K. Leabman(IGM Biosciences (United States)), Dean Ng(IGM Biosciences (United States)), Keyu Li(Sichuan University), Poonam Yakkundi(IGM Biosciences (United States)), Bruce A. Keyt, Genevive Hernandez(Sutro Biopharma (United States)), Angus M. Sinclair(LabGenius (United Kingdom)), Thomas Manley(IGM Biosciences (United States))
Cited by 1
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Relationship between Plasma Levels of Lipopolysaccharide (LPS) and LPS‐Binding Protein in Patients with Severe Sepsis and Septic Shock
|The Journal of Infectious Diseases|1999|611
Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution.
|Proceedings of the National Academy of Sciences|1986|518
Crystal Structure of Human BPI and Two Bound Phospholipids at 2.4 Angstrom Resolution
|Science|1997|360
Structure, Function, and Therapeutic Use of IgM Antibodies
|Antibodies|2020|257